SLC6A14 and 5-HTR2C polymorphisms are associated with food intake and nutritional status in children

Clinical Biochemistry

Volumn 48, Issue 18, 2015, Pages 1277-1282

  Miranda, Raquel C K ^a   Vetter, Silvia B ^a   Genro, Júlia P ^a   Campagnolo, Paula D B ^a   Mattevi, Vanessa S ^a   Vitolo, Márcia R ^a   Almeida, Silvana ^a  

^a UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

Children; Eating; Genetic polymorphism; Obesity; Serotonin

Indexed keywords

5 HTR2C GENE; ARTICLE; BLOOD SAMPLING; CALORIC INTAKE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEVELOPMENTAL STAGE; FEMALE; FOOD INTAKE; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SINGLE NUCLEOTIDE POLYMORPHISM; SLC6A14 GENE; SUGAR INTAKE; ALLELE; EATING; GENE EXPRESSION; GENETICS; GENOTYPE; HETEROZYGOTE; INFANT; PRESCHOOL CHILD;

AMINO ACID TRANSPORTER; SEROTONIN 2C RECEPTOR; SLC6A14 PROTEIN, HUMAN;

ALLELES; AMINO ACID TRANSPORT SYSTEMS, NEUTRAL; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; EATING; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INFANT; MALE; NUTRITIONAL STATUS; POLYMORPHISM, SINGLE NUCLEOTIDE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECEPTOR, SEROTONIN, 5-HT2C;

EID: 84949095092     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2015.07.003     Document Type: Article

References (33)

1. Progress in preventing childhood obesity: how do we measure up? 2007, 494. Committee on Progress in Preventing Childhood Obesity.
2. Pratt W.E., Blackstone K. Nucleus accumbens acetylcholine and food intake: decreased muscarinic tone reduces feeding but not food-seeking. Behav. Brain Res. 2009, 198:252-257.
3. Czachowski C.L. Manipulations of serotonin function in the nucleus accumbens core produce differential effects on ethanol and sucrose seeking and intake. Alcohol. Clin. Exp. Res. 2005, 29:1146-1155.
4. Bray G.A. Obesity: the disease. J. Med. Chem. 2006, 49:4001-4007.
5. Hebebrand J., Sommerlad C., Geller F., Gorg T., Hinney A. The genetics of obesity: practical implications. Int. J. Obes. Relat. Metab. Disord. 2001, 25(Suppl. 1):S10-S18.
6. Magalhaes C.P., de Freitas M.F., Nogueira M.I., Campina R.C., Takase L.F., de Souza S.L., et al. Modulatory role of serotonin on feeding behavior. Nutr. Neurosci. 2010, 13:246-255.
7. Hoglund P.J., Adzic D., Scicluna S.J., Lindblom J., Fredriksson R. The repertoire of solute carriers of family 6: identification of new human and rodent genes. Biochem. Biophys. Res. Commun. 2005, 336:175-189.
8. Suviolahti E., Oksanen L.J., Ohman M., Cantor R.M., Ridderstrale M., Tuomi T., et al. The SLC6A14 gene shows evidence of association with obesity. J. Clin. Invest. 2003, 112:1762-1772.
9. Durand E., Boutin P., Meyre D., Charles M.A., Clement K., Dina C., et al. Polymorphisms in the amino acid transporter solute carrier family 6 (neurotransmitter transporter) member 14 gene contribute to polygenic obesity in French Caucasians. Diabetes 2004, 53:2483-2486.
10. Bah J., Westberg L., Baghaei F., Henningsson S., Rosmond R., Melke J., et al. Further exploration of the possible influence of polymorphisms in HTR2C and 5HTT on body weight. Metab. Clin. Exp. 2010, 59:1156-1163.
11. Opgen-Rhein C., Brandl E.J., Muller D.J., Neuhaus A.H., Tiwari A.K., Sander T., et al. Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sample. Pharmacogenomics 2010, 11:773-780.
12. Mulder H., Franke B., van der-Beek van der A.A., Arends J., Wilmink F.W., Egberts A.C., et al. The association between HTR2C polymorphisms and obesity in psychiatric patients using antipsychotics: a cross-sectional study. Pharmacogenomics J. 2007, 7:318-324.
13. Vitolo M.R., Bortolini G.A., Feldens C.A., Drachler M.L. Impacts of the 10 Steps to Healthy Feeding in Infants: a randomized field trial. Cad Saude Publica 2005, 21:1448-1457.
14. Galvao A.C., Kruger R.C., Campagnolo P.D., Mattevi V.S., Vitolo M.R., Almeida S. Association of MAOA and COMT gene polymorphisms with palatable food intake in children. J. Nutr. Biochem. 2012, 23:272-277.
15. Lahiri D.K., Nurnberger J.I. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 1991, 19:5444.
16. Lappalainen J., Zhang L., Dean M., Oz M., Ozaki N., Yu D.H., et al. Identification, expression, and pharmacology of a Cys23-Ser23 substitution in the human 5-HT2c receptor gene (HTR2C). Genomics 1995, 27:274-279.
17. Ribases M., Fernandez-Aranda F., Gratacos M., Mercader J.M., Casasnovas C., Nunez A., et al. Contribution of the serotoninergic system to anxious and depressive traits that may be partially responsible for the phenotypical variability of bulimia nervosa. J. Psychiatr. Res. 2008, 42:50-57.
18. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
19. Long J.C. Multiple locus haplotype analysis. Section on population genetics and linkage 1999, Laboratory of Neurogenetics, NIAAA, National Institutes of Health, Bethesda, MD. 2.0 ed.
20. Dez passos da alimentação saudável: guia alimentar para crianças menores de dois anos 2002, Ministério da Saúde, Brasil, Brasília - DF.
21. Marston O.J., Heisler L.K. Targeting the serotonin 2C receptor for the treatment of obesity and type 2 diabetes. Neuropsychopharmacology 2009, 34:252-253.
22. Bruce K.R., Steiger H., Young S.N., Kin N.M., Israel M., Levesque M. Impact of acute tryptophan depletion on mood and eating-related urges in bulimic and nonbulimic women. J. Psychiatry Neurosci. 2009, 34:376-382.
23. Benton D. Carbohydrate ingestion, blood glucose and mood. Neurosci. Biobehav. Rev. 2002, 26:293-308.
24. Tecott L.H., Sun L.M., Akana S.F., Strack A.M., Lowenstein D.H., Dallman M.F., et al. Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature 1995, 374:542-546.
25. Bonhaus D.W., Weinhardt K.K., Taylor M., DeSouza A., McNeeley P.M., Szczepanski K., et al. RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist. Neuropharmacology 1997, 36:621-629.
26. Basile V.S., Masellis M., McIntyre R.S., Meltzer H.Y., Lieberman J.A., Kennedy J.L. Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle. J. Clin. Psychiatry 2001, 62(Suppl. 23):45-66.
27. Buckland P.R., Hoogendoorn B., Guy C.A., Smith S.K., Coleman S.L., O'Donovan M.C. Low gene expression conferred by association of an allele of the 5-HT2C receptor gene with antipsychotic-induced weight gain. Am. J. Psychiatry 2005, 162:613-615.
28. Godlewska B.R., Olajossy-Hilkesberger L., Ciwoniuk M., Olajossy M., Marmurowska-Michalowska H., Limon J., et al. Olanzapine-induced weight gain is associated with the -759C/T and -697G/C polymorphisms of the HTR2C gene. Pharmacogenomics J. 2009, 9:234-241.
29. Laika B., Leucht S., Heres S., Schneider H., Steimer W. Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome. Pharmacogenomics J. 2010, 10:20-29.
30. Risselada A.J., Vehof J., Bruggeman R., Wilffert B., Cohen D., Al Hadithy A.F., et al. Association between HTR2C gene polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study. Pharmacogenomics J. 2012, 12:62-67.
31. Theisen F.M., Hinney A., Bromel T., Heinzel-Gutenbrunner M., Martin M., Krieg J.C., et al. Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and clozapine-induced weight gain among German schizophrenic individuals. Psychiatr. Genet. 2004, 14:139-142.
32. Kring S.I., Werge T., Holst C., Toubro S., Astrup A., Hansen T., et al. Polymorphisms of serotonin receptor 2A and 2C genes and COMT in relation to obesity and type 2 diabetes. PLoS One 2009, 4:e6696.
33. Basile V.S., Masellis M., De Luca V., Meltzer H.Y., Kennedy J.L. 759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain. Lancet 2002, 360:1790-1791.